Category Archives: Stem Cell Research

Lecture: Stem Cells and Tissue Regeneration Lecture delivered on October 6, 2009 at Stanford University (1 hour 50 minutes) Dr. Jill Helms, Associate Professor of Surgery at the Stanford School of Medicine, discusses developments in stem cell research and the future of regenerative medicine. By: StemGenics … Continue reading →

Stem cell meeting_ Announcement.mov The society of stem cell research, Thailand By: DITSAYADSP … Continue reading →

Lutz, Florida (PRWEB) February 05, 2013 World Stem Cells, LLC. contract laboratory and clinic World Stem Cells Clinic a new adult stem cell laboratory being built in Cancun, Mexico to support Stem Cell research, stem cell clinical trials and stem cell treatments. This was accomplished by private funding in conjunction with World Stem Cells, LLC worldstemcells.com a US patient management company, Medicina Biocelular Avanzada , S.E. de C.V. a Mexican patient management company and World Stem Cells Clinic of Cancun, a Stem Cell treatment Clinic http://worldstemcells.com/clinic-team.html well known board certified hematologist and physicians , in Cancun. The laboratory http://worldstemcells.com/stem-cell-laboratory construction is complete and operations were transferred to our new facility. This facility provides Cancun, and patient around the world, a state of the art cGTP laboratory to support their stem cell treatments in a beautiful, and positive environment. The lab was designed and constructed to provide one ISO7 lab, one wet lab along with a treatment area. This will allow stem cell retrieval, testing, culturing, selection, counting, analyses and sorting along with cryopreservation, without removal from the lab. This all in house capability reduces the possibility of contamination and errors. Dr. M. Abblitt will operate the Lab under cGTP guidelines … Continue reading →

Scientists have taken a step closer to creating artificial human organs and using them for transplants after 3D printing produced clusters of stem cells. In the short term, the technique could be used to generate tissue for drug-testing currently carried out on animals. The 3D printing technology relies on an adjustable "microvalve", which builds up layers of human embryonic stem cells. Such cells, which originate from early stage embryos, are blankslates with the potential to become any type of tissue in the body. In the long term, the new printing technique could pave the way for those cells to be incorporated into transplant-ready laboratory-made organs and tissues, said researchers at Heriot-Watt University in Edinburgh The technique's breakthrough is in its gentle handling of the delicate cells which gives them a greater chance to thrive, they said. Lead scientist Dr Will Shu told Sky News: "We found that the valve-based printing is gentle enough to maintain high stem cell viability". He also said it was "accurate enough to produce spheroids of uniform size and, most importantly, the printed human embryo stem cells maintained their pluripotency - the ability to differentiate into any other cell type". Taking a cell from a patient … Continue reading →

PITTSTON, ME--(Marketwire - Feb 5, 2013) - YaFarm Technologies, Inc. ( PINKSHEETS : YFRM ) (YaFarm, or the Company) is pleased to announce that it has signed a definitive agreement to acquire the Integrative Stem Cell Institute (the ISCI). The ISCI is a pioneer in the field of cell-based regenerative medicine. Combining a world-class medical facility with a state-of-the-art laboratory, the ISCI provides investigational treatments to patients as part of clinical studies, while providing long-term follow up to advance these promising therapies. The acquisition of the ISCI provides the Company with an entry into stem cell research and treatment. With the advent of regenerative medicine, clinics such as the ISCI have taken the years of scientific research and started to apply them to treatment of patients. YaFarm Technologies President Brian Hermenze stated, "Since the 2012 Nobel Prize in Physiology or Medicine was awarded jointly to John B. Gurdon and Shinya Yamanaka for their work in stem cell research, we are very excited about the synergies this acquisition will bring to the Company. The ISCI has been providing point-of-care therapies to patients for over a year and operates at an internationally recognized medical facility accredited by both the Joint Commission and … Continue reading →

PITTSTON, ME--(Marketwire - Feb 5, 2013) - YaFarm Technologies, Inc. ( PINKSHEETS : YFRM ) (YaFarm, or the Company) is pleased to announce that it has signed a definitive agreement to acquire the Integrative Stem Cell Institute (the ISCI). The ISCI is a pioneer in the field of cell-based regenerative medicine. Combining a world-class medical facility with a state-of-the-art laboratory, the ISCI provides investigational treatments to patients as part of clinical studies, while providing long-term follow up to advance these promising therapies. The acquisition of the ISCI provides the Company with an entre into stem cell research and treatment. With the advent of regenerative medicine, clinics such as the ISCI have taken the years of scientific research and started to apply them to treatment of patients. YaFarm Technologies CEO Brian Hermenze stated, "Since the 2012 Nobel Prize in Physiology or Medicine was awarded jointly to John B. Gurdon and Shinya Yamanaka for their work in stem cell research, we are very excited about the synergies this acquisition will bring to the Company. The ISCI has been providing point-of-care therapies to patients for over a year and operates at an internationally recognized medical facility accredited by both the Joint Commission and … Continue reading →

Published Monday, February 4, 2013, 8:08 AM Updated Monday, February 4, 2013, 8:08 AM As part of austerity measures, Ireland chose to abolish - or absorb into another position - the role of the chief science adviser Photo by Andrei Tchernov Austerity certainly had an impact on Ireland, and the sciences werent spared from the influence. As part of austerity measures, Ireland chose to abolish - or absorb into another position - the role of the chief science adviser, a position that had been around since 2005, in late 2012. According to Nature.com, the CSA helped to persuade the government to spare science, and urged it not to neglect longer-term investments in research capacity, in the wake of the 2008 Irish financial crisis. Since the abolishment of the role, many scientists and researchers in Ireland worry that their work may suffer as a result. One foundation, the Irish Stem Cell Foundation, is particularly against the move to abolish the role of the CSA. The Irish Stem Cell Foundation is an independent, non-profit medical research charity. Established in October 2009, it is composed of researchers, clinicians, patients advocates, patients, science communicators, bioethicists, lawyers, teachers, and students. Stem cells are of particular … Continue reading →

TORONTO - Two small Canadian life science research companies are planning to combine forces to focus on treating cancer with stem cell technologies Stem Cell Therapeutics Corp. (TSXV:SSS) will acquire Trillium Therapeutics Inc., both headquartered in Toronto, but all of Trillium's executives and staff will remain with the new company being created and Trillium's chief executive will be its CEO. Under terms of the deal, Trillium's security holders are to receive $1.2 million in cash and shares in the new company also to be called Stem Cell Therapeutics valued at $1.65 million. Trillium CEO Niclas Stiernholm, who is also a director of Stem Cell Therapeutics Corp., will be chief executive of the combined company. Trillium is a private company that was created to advance work done by six Ontario research institutions. It currently has two oncology research programs at the preclinical stage. Stem Cell Therapeutics if focused on acquiring technologies and capital to advance treatments towards commercialization. See the original post here: Two life sciences firms to join forces, create larger Stem Cell Therapeutics … Continue reading →

February 4, 2013 Brett Smith for redOrbit.com Your Universe Online As stem cell research progresses, scientists are becoming more and more specialized in studying the types of cells and tissues that they generate. In pursuing the mechanisms that drive stem cell specialization, scientists at the Monell Chemical Senses Center in Philadelphia have identified certain genetic characteristics of taste stem cells and their location on the tongue, according to their report in the journal Stem Cells. Cancer patients who have taste loss following radiation to the head and neck and elderly individuals with diminished taste function are just two populations who could benefit from the ability to activate adult taste stem cells, said study co-author Dr. Robert Margolskee, a molecular neurobiologist at Monell. Taste stems cells differentiate into three different types of taste cells, all of which are found within the tiny taste buds that dot the tongue. Two types of taste cells, also referred to as gustatory cells, contain chemoreceptors that convey the various kinds of taste, including bitter, sweet, sour and umami. The third type of taste cell performs more of a structural function. One of the remarkable properties of taste cells is their ability to regenerate. All three … Continue reading →

Every week, it seems, there's a new breakthrough in 3-D printing that promises us the ability to (eventually) fabricate some new thing in one of those glass-walled wonder boxes. Such things have included everything from spare parts for the International Space Station above to the beef on our dinner plates to the organs inside our bodies. Although this last idea of fabricating body parts may seem the most fanciful, a team of scientists is reporting a breakthrough in the 3-D printing using human embryonic stem cells that could purportedly lead to life-like bioengineered tissue and, eventually, artificial organs tailor-made for specific patients.Researchers have been able to engineer tissue samples in the past by combining artificial scaffold-like structures and animal cells. Depositing human embryonic stem cells in cultures using a 3-D printer offers some advantages. In particular, the cells can be positioned in droplets of uniform size cheaper, faster and more easily than using manual methods. This uniformity is important for researchers trying to generate specific cell types.Whereas human embryonic stem cells have proved too fragile to print in the past, scientists at Scotland's Heriot-Watt University and Roslin Cellab, a stem cell technology company, say they have developed a new technique … Continue reading →